Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 9:32 AM ISTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...
DBV Technologies peanut allergy drug fails key study Ruby Khatun Khatun23 Oct 2017 9:15 AM ISTDBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
Anpac Bio surpasses 50,000 case study milestone Liquid Biopsy Pioneer serving individual, medical, insurance and corporate customers Ruby Khatun Khatun23 Oct 2017 9:00 AM ISTSACRAMENTO, California: Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced...
No change in essential drugs ceiling price calculation: Government Ruby Khatun Khatun22 Oct 2017 11:48 AM ISTNew Delhi: The government said it is not considering any changes in the methodology for calculating ceiling prices of scheduled medicines although it...
Dr Reddys Lab recalls Famotidine tablets from US market Ruby Khatun Khatun22 Oct 2017 10:17 AM ISTNew Delhi: Dr. Reddy's Laboratories has initiated voluntarily recall of over half a million Famotidine tablets bottles from the US market as the drug...
California judge tosses 417 million dollars talc cancer verdict against Johnson and Johnson Ruby Khatun Khatun22 Oct 2017 10:01 AM ISTA California judge on Friday threw out a $417 million verdict against Johnson and Johnson in a lawsuit by a woman who claimed she developed ovarian...
GlaxoSmithKline adult shingles vaccine wins US approval Ruby Khatun Khatun22 Oct 2017 9:31 AM ISTThe U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected...
Imprimis Pharma to take on Allergans Restasis with cheaper product Ruby Khatun Khatun22 Oct 2017 9:02 AM ISTShares of Imprimis Pharmaceuticals Inc sky-rocketed as much as 91 percent on Thursday, after the company said it would launch a cheaper alternative to...
Gilead cancer immunotherapy wins US approval with 373,000 dollars price Ruby Khatun Khatun21 Oct 2017 10:59 AM ISTA new therapy for a type of lymphoma developed by Kite Pharma, which was acquired by Gilead Sciences Inc, won U.S. approval on Wednesday, marking the...
Trump promises action on drug prices that may impact India Ruby Khatun Khatun21 Oct 2017 9:30 AM ISTWashington: US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Novartis Revolade shows long-term disease control for chronic/persistent immune thrombocytopenia Ruby Khatun Khatun21 Oct 2017 9:09 AM ISTZURICH: Novartis said on Wednesday a long-term study of its Revolade drug showed good results in treating chronic and persistent immune...
